InvestorsHub Logo
Followers 11
Posts 573
Boards Moderated 0
Alias Born 02/12/2016

Re: None

Thursday, 08/11/2016 6:17:07 PM

Thursday, August 11, 2016 6:17:07 PM

Post# of 463451
For those who may not be aware of the amounts of the grants the company has received. Not extremely significant but it shows that the science makes sense to people who understand it and are willing to provide funding with the sole purpose of encouraging research to find cures for such devastating diseases. Hopefully Dr. M. can secure some funding from the US government for AD. From the 10-q:

"During the year ended September 30, 2015, the Company was awarded grant funding in the amount of $286,455, of which the Company has received $143,228, and the remainder will be received in equal semi-annual installments over the 24-month commitment. The grant was received in exchange for a commitment to provide research and development for preclinical validation of Sigma-1 receptor agonism as potential treatment for Parkinsons’ disease.

The grant income was deferred and is being amortized as an increase to other income over a two-year period as the related research and development expenditures are incurred. During the three and nine months ended June 30, 2016, the Company recognized $47,767 and $113,701, respectively (2015: $0 and $0, respectively) of this grant on its statement of operations.

During the nine months ended June 30, 2016, the Company recognized other grant income of $571,093 in respect of a research and development incentive program offered by the Australian government."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News